MA

Mohammad Azaj

Active Director Managing Director DIN 10234485
DIN 10234485 First appointment Jul 2023
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Mohammad Azaj

Data last updated:

Mohammad Azaj is a Managing Director at Maichwin India Remedies Private Limited (since 2023).

DIN 10234485
Primary Designation Managing Director
First Appointment 11 Jul 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Managing Director11 Jul 20232023Active

Board colleagues of Mohammad Azaj

NameDINCompanyDesignation
Mohammad Asif10234486Maichwin India Remedies Private LimitedDirector

Directorship timeline

Open interactive timeline →
Maichwin India Remedies Private Limited
Premium access

Shareholding and investment profile for Mohammad Azaj

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohammad Azaj

Mohammad Azaj currently holds 1 directorship: Maichwin India Remedies Private Limited (Managing Director, since 11 Jul 2023).

Mohammad Azaj was first appointed on 11 Jul 2023 as Managing Director at Maichwin India Remedies Private Limited.

The current boards of Mohammad Azaj's companies include Mohammad Asif (Maichwin India Remedies Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available